ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Sasanlimab As Maintenance Treatment Based on Clinical Response to Neoadjuvant Treatment in Molecularly Categorized Muscle Invasive Bladder Cancer Patients

Fundación de investigación HM · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
mibc, muscle invasive bladder cancer, sparing, cystectomy, gemcitabine, cisplatine, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 829741
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.